SCHEMBL10121851

SCHEMBL10121851

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CNC(=O)NCC2CCCCC2)n[nH]1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.56
ACHE P22303 1/20 0.39
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
MMP3 P08254 1/20 0.33
EPHX1 P07099 1/20 0.33
GAA P10253 1/20 0.33
NAPEPLD Q6IQ20 4/20 0.33
REN P00797 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
NAMPT P43490 1/20 0.32
AGTR1 P30556 1/20 0.32
AGTR2 P50052 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709717 0.90 GHSR (0.57) GHSRSMN1; SMN2EPHX1GAA
SCHEMBL10121950 0.89 GHSR (0.64) GHSRACHEALDH1A1LMNASMN1; SMN2
SCHEMBL1709597 0.89 GHSR (0.53) GHSRACHEALDH1A1LMNASMN1; SMN2
SCHEMBL10121679 0.88 GHSR (0.57) GHSRSMN1; SMN2EPHX1GAA
SCHEMBL10121684 0.88 GHSR (0.59) GHSRLMNASMN1; SMN2PPARGEPHX1
SCHEMBL1709684 0.88 GHSR (0.62) GHSRALDH1A1GAANAPEPLD
SCHEMBL10122180 0.88 GHSR (0.57) GHSRACHEALDH1A1LMNAGAA
SCHEMBL10121689 0.87 GHSR (0.61) GHSRALDH1A1LMNASMN1; SMN2GAA
SCHEMBL1709615 0.87 GHSR (0.61) GHSRACHEALDH1A1LMNAGAA
SCHEMBL1709620 0.87 GHSR (0.56) GHSRSMN1; SMN2GAAAGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885ACHE 3696/4885NPSR1 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.